VRS
MYGN icon

Virginia Retirement Systems’s Myriad Genetics MYGN Stock Holding History

Virginia Retirement Systems’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,400
Closed -$218K – 1197
2022
Q3 		$218K Buy
+11,400
New +$262K ﹤0.01% 1035
2020
Q3 		– Sell
-36,300
Closed -$412K – 1143
2020
Q2 		$412K Sell
36,300
-8,200
-18% -$116K ﹤0.01% 869
2020
Q1 		$637K Sell
44,500
-1,900
-4% -$40.1K 0.01% 711
2019
Q4 		$1.26M Sell
46,400
-1,400
-3% -$38.5K 0.01% 595
2019
Q3 		$1.37M Buy
47,800
+4,900
+11% +$143K 0.02% 565
2019
Q2 		$1.19M Buy
42,900
+2,100
+5% +$59.3K 0.01% 611
2019
Q1 		$1.35M Buy
40,800
+1,100
+3% +$33.5K 0.02% 557
2018
Q4 		$1.15M Buy
39,700
+13,400
+51% +$482K 0.02% 570
2018
Q3 		$1.21M Sell
26,300
-2,300
-8% -$102K 0.01% 640
2018
Q2 		$1.07M Buy
+28,600
New +$966K 0.01% 662
2018
Q1 		– Sell
-43,600
Closed -$1.5M – 1033
2017
Q4 		$1.5M Sell
43,600
-4,900
-10% -$165K 0.02% 553
2017
Q3 		$1.75M Sell
48,500
-12,300
-20% -$351K 0.02% 537
2017
Q2 		$1.57M Buy
60,800
+12,000
+25% +$255K 0.02% 528
2017
Q1 		$937K Buy
+48,800
New +$865K 0.01% 672
2015
Q4 		$229K Sell
5,300
-2,900
-35% -$123K ﹤0.01% 931
2015
Q3 		$307K Hold
8,200
– – ﹤0.01% 823
2015
Q2 		$279K Hold
8,200
– – ﹤0.01% 861
2015
Q1 		$290K Hold
8,200
– – ﹤0.01% 844
2014
Q4 		$279K Hold
8,200
– – ﹤0.01% 835
2014
Q3 		$316K Hold
8,200
– – 0.01% 795
2014
Q2 		$319K Sell
8,200
-600
-7% -$22.3K 0.01% 800
2014
Q1 		$301K Sell
8,800
-21,200
-71% -$657K 0.01% 788
2013
Q4 		$629K Sell
30,000
-11,400
-28% -$288K 0.01% 576
2013
Q3 		$973K Buy
41,400
+4,700
+13% +$134K 0.02% 470
2013
Q2 		$986K Buy
+36,700
New +$1.06M 0.02% 449

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Virginia Retirement Systems's MYGN Position: Q4 2022 in Review

Virginia Retirement Systems sold out of Myriad Genetics (MYGN) in Q4 2022, closing a stake of 11,400 shares — an estimated $218K sold.

Virginia Retirement Systems first reported a position in MYGN in Q2 2013 and held it in 25 quarters. The position peaked at $1.75M in Q3 2017. 197 funds tracked by Wall St. Rank hold MYGN as of Q4 2022.

  • Virginia Retirement Systems reported no remaining Myriad Genetics position as of Q4 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,400 Myriad Genetics shares in Q4 2022, an estimated $218K.
  • Virginia Retirement Systems first reported a position in Myriad Genetics in Q2 2013 and held it in 25 quarters.
  • Virginia Retirement Systems's Myriad Genetics position peaked at $1.75M in Q3 2017.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2022.

Based on Virginia Retirement Systems's 13F filing for Q4 2022, filed 17 May 2023.